By Izzy Wood (Drug Target Review)2023-07-27T16:00:57
US researchers say new mechanism could lead to new drugs and therapies to treat normal cognitive decline in aging.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, By Drug Target Review
2023-09-06T16:55:04
Sponsored by NanoTemper Technologies
2024-01-26T13:22:42
Sponsored by bit.bio
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2026-08-04T08:39:00
Author Paul Michaels
2026-07-21T09:36:00
Contributor Jayson Uffens, By Drug Target Review
2023-07-04T10:05:58
Sponsored by Revvity
Site powered by Webvision Cloud